翔宇医疗XIANGYU品牌怎么样 申请店铺

我要投票 翔宇医疗XIANGYU在医疗器械行业中的票数:689 更新时间:2026-01-24
翔宇医疗XIANGYU是哪个国家的品牌?「翔宇医疗XIANGYU」是安阳市翔宇医疗设备有限责任公司旗下著名品牌。该品牌发源于河南省安阳市,由创始人郭 * 玲在2002年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力翔宇医疗XIANGYU品牌出海!将品牌入驻外推网,定制翔宇医疗XIANGYU品牌推广信息,可以显著提高翔宇医疗XIANGYU产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

翔宇医疗XIANGYU怎么样

翔宇医疗(XIANGYU MEDICAL)成立于2002年,注册资金6200万元,是一家专注于康复理疗设备和创伤治疗设备的研发、生产、销售为一体的企业,生产基地位于中国内黄县产业集聚区。截止2017年4月底,公司拥有员工800余人,产品注册证48个。

主要产品涵盖:声疗、光疗、电疗、磁疗、冷疗、热疗、蜡疗、汽疗、音乐疗法、压力疗法、按摩疗法、牵引疗法、PT运动疗法、OT作业疗法、ST语言疗法、康复评测产品及进口康复产品,共有产品700多种型号,所有产品均为卫计委康复中心建设要求配置的品种;产品遍布全国各级医疗单位,并已出口到欧洲、非洲、澳洲、中东及东南亚等国家。与德国、美国、韩国、意大利、英国等多个国家的康复设备生产企业建立战略合作关系。

翔宇医疗竭诚为全国残联系统、民政系统提供一、二、三级康复中心(医院)建设方案、疼痛治疗中心提供整体解决方案、专项解决方案、单个设备和设备组合的规划设计方案及技术支持。翔宇医疗为方案实施提供所在区域市场调研和SWOT分析的学科发展定位,并以此提供专业科室规划服务、人才培养计划、科室管理保障、信息化网络技术等支持。

截止2016年11月,市场覆盖全国31个省市,渠道合作伙伴10000余家,市场覆盖率达到40%以上,直接服务10万余家医疗机构,为数亿患者解决康复问题。

2012年翔宇医疗投资6亿元,占地面积500余亩,12万平方标准化车间。专注打造国内较大的康复理疗设备制造中心和全国较大的中医诊疗设备生产示范基地之一。2017年公司计划打造国际健康城,健康城一期项目工程计划投资30亿元,项目包含:三级甲等康复医院、养老中心、国际会议中心、康复医学博物馆、康复设备展览馆、康复技术研究院等标志性工程。


Xiangyu medical, founded in 2002 with a registered capital of 62 million yuan, is an enterprise focusing on the R & D, production and sales of rehabilitation physical therapy equipment and trauma treatment equipment. Its production base is located in the industrial cluster of Neihuang County, China. By the end of April 2017, the company has more than 800 employees and 48 product registration certificates. The main products include: acoustic therapy, phototherapy, electrotherapy, magnetic therapy, cold therapy, hyperthermia, wax therapy, steam therapy, music therapy, pressure therapy, massage therapy, traction therapy, Pt sports therapy, OT operation therapy, St language therapy, rehabilitation evaluation products and imported rehabilitation products. There are more than 700 types of products, all of which are required by the construction of the rehabilitation center of the health and Family Planning Commission Products all over the country at all levels of medical units, and has been exported to Europe, Africa, Australia, the Middle East and Southeast Asia and other countries. Establish strategic cooperation with rehabilitation equipment manufacturers in Germany, the United States, South Korea, Italy, the United Kingdom and other countries. Xiangyu medical wholeheartedly provides the first, second and third level Rehabilitation Center (hospital) construction scheme, pain treatment center with overall solution, special solution, planning and design scheme and technical support of single equipment and equipment combination for the national disabled persons' Federation system and civil affairs system. Xiangyu medical provides the discipline development orientation of regional market research and SWOT analysis for the implementation of the plan, and provides professional department planning services, personnel training plan, department management guarantee, information network technology and other support. As of November 2016, the market has covered 31 provinces and cities nationwide, more than 10000 channel partners, with a market coverage rate of more than 40%, directly serving more than 100000 medical institutions, and solving rehabilitation problems for hundreds of millions of patients. In 2012, Xiangyu medical investment reached 600 million yuan, covering an area of more than 500 mu and 120000 square meters of standardized workshops. Focus on building a large rehabilitation physiotherapy equipment manufacturing center in China and one of the large production demonstration bases of TCM diagnosis and treatment equipment in China. In 2017, the company plans to build an international health city. The first phase of the project is planned to invest 3 billion yuan. The project includes three class a rehabilitation hospitals, pension centers, international conference centers, rehabilitation medicine museums, rehabilitation equipment exhibition halls, rehabilitation technology research institutes and other landmark projects.

本文链接: https://brand.waitui.com/b84b5c08f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

52分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

52分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

52分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

52分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

52分钟前

本页详细列出关于翔宇医疗XIANGYU的品牌信息,含品牌所属公司介绍,翔宇医疗XIANGYU所处行业的品牌地位及优势。
咨询